News

  • Logo of ANS 2012See and hear about my most recent work regarding Neuregulin and Schizophrenia at the Australian Neuroscience Society  Annual Conference 2012 (ANS 2012, Gold Coast, AU):
    Oral presentation session 9, Tuesday, 31. January 2012, 11:00-11:15 AM,
    (Oral Abstract ORAL-09-07 can be found on conference website)

ANS 2012 Presentation

NRG1 and Schizophrenia Treatment

Presented at: Annual Meeting of the Australian Neuroscience Society 2012, Gold Coast , Australia.

Please read on for details of the references I mentioned throughout my presentation:

Continue reading

About Me

I, Martin Engel, am a graduate student at the University of Wollongong and currently in the second year of my PhD, focusing on the neuroimmunology of Schizophrenia. Before starting my PhD in August 2010, I graduated with a Bachelor of Science (Hons.) in Neuroscience from Cardiff University in June of the same year. Continue reading

SfN 2009 Poster

Effect of chronic D-Amphetamine and Phencyclidine treatment on cortical Inhibitory Interneurons

Presented at: Society for Neuroscience annual conference, Chicago, 2009
Engel M a, b, Sandager-Nielsen K a, Thomsen MS a,c, Mikkelsen JD c, Mirza NR a
a Dept In Vivo Pharmacology, NeuroSearch A/S, 93 Pederstrupvej, DK-2750 Ballerup, Denmark
b School of Biosciences, Cardiff University, Cardiff, United Kingdom
c Neurobiology Research Unit, University Hospital Copenhagen

Continue reading

BAP 2009 Poster / A

Effect of chronic D-Amphetamine and Phencyclidine treatment on Parvalbumin expressing interneurons.

Presented at: British Association for Psychopharmacology annual summer conference, Oxford, 2009
Engel M a, b, Sandager-Nielsen K a, Thomsen S M a, Mirza NR a
a Dept In Vivo Pharmacology, NeuroSearch A/S, 93 Pederstrupvej, DK-2750 Ballerup, Denmark
b School of Biosciences, Cardiff University, Cardiff, United Kingdom

Continue reading